Medicare Enrolled

Dr. Vidhya Subramanian, MD

Endocrinology · Katy, TX
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
1450 W GRAND PKWY S, Katy, TX 77494
8328379919
Registered in NPPES since 2006
NPI: 1295752004 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Subramanian from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Subramanian? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Subramanian

Dr. Vidhya Subramanian is an endocrinology specialist in Katy, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Subramanian performed 1,147 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Subramanian received a total of $8,971 from 46 pharmaceutical and/or device companies across 489 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Subramanian is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration ▲ Top 36% volume in TX $8,971 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
1,147
Medicare services
Top 36% in TX for endocrinology
Not available
Unique patients (not deduplicated)
$74
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
782 $82 $236
Continuous glucose monitoring with interpretation
This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results.
141 $26 $95
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
135 $58 $159
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
74 $110 $363
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
15 $63 $238
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$8,971
Total received (2018-2024)
Avg $1,282/year across 7 years
Top 34% in TX for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
46
Companies
489
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,426
2023
$3,192
2022
$576
2021
$72
2020
$226
2019
$560
2018
$921

Payments by company (2024)

Lilly USA, LLC
$392
Amgen Inc.
$369
Novo Nordisk Inc
$284
Insulet Corporation
$223
Dexcom, Inc.
$207
Mannkind Corporation
$193
Radius Health, Inc.
$183
SANOFI-AVENTIS U.S. LLC
$171
Corcept Therapeutics
$147
Bayer Healthcare Pharmaceuticals Inc.
$138
Boehringer Ingelheim Pharmaceuticals, Inc.
$138
Tandem Diabetes Care, Inc.
$134
Antares Pharma, Inc.
$110
Amneal Pharmaceuticals LLC
$106
ABBVIE INC.
$97
Embecta Corp.
$62
Madrigal Pharmaceuticals
$60
Kyowa Kirin, Inc.
$53
CeQur Corporation
$50
Ascensia Diabetes Care Us Inc.
$38
Alexion Pharmaceuticals, Inc.
$36
Abbott Laboratories
$35
Ultragenyx Pharmaceutical Inc.
$34
BETA BIONICS, INC.
$34
Xeris Pharmaceuticals, Inc.
$30
Esperion Therapeutics, Inc.
$28
Acella Pharmaceuticals, LLC
$21
Novartis Pharmaceuticals Corporation
$18
Verity Pharmaceuticals Inc.
$16
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$16
Top 3 companies account for 30.5% of 2024 payments
All-time payments by company (2018-2024) ›
Lilly USA, LLC
$1,019
AstraZeneca Pharmaceuticals LP
$891
Novo Nordisk Inc
$851
Amgen Inc.
$674
Radius Health, Inc.
$562
SANOFI-AVENTIS U.S. LLC
$550
Dexcom, Inc.
$354
MannKind Corporation
$338
Boehringer Ingelheim Pharmaceuticals, Inc.
$312
Bayer Healthcare Pharmaceuticals Inc.
$296
Amneal Pharmaceuticals LLC
$284
Insulet Corporation
$223
Embecta Corp.
$214
Antares Pharma, Inc.
$200
Abbott Laboratories
$196
Mannkind Corporation
$193
AbbVie Inc.
$182
Tandem Diabetes Care, Inc.
$156
Corcept Therapeutics
$147
Alexion Pharmaceuticals, Inc.
$141
Medtronic, Inc.
$140
Xeris Pharmaceuticals, Inc.
$134
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$105
ABBVIE INC.
$97
CeQur Corporation
$75
Novartis Pharmaceuticals Corporation
$64
Madrigal Pharmaceuticals
$60
Horizon Therapeutics plc
$56
Kyowa Kirin, Inc.
$53
AbbVie, Inc.
$39
Ascensia Diabetes Care Us Inc.
$38
Ultragenyx Pharmaceutical Inc.
$34
BETA BIONICS, INC.
$34
Averitas Pharma Inc.
$30
Janssen Pharmaceuticals, Inc
$29
Esperion Therapeutics, Inc.
$28
Ascendis Pharma Inc
$22
Acella Pharmaceuticals, LLC
$21
RECORDATI_RARE_DISEASES_INC.
$20
Supernus Pharmaceuticals, Inc.
$17
IBSA Pharma Inc.
$17
Currax Pharmaceuticals LLC
$17
Verity Pharmaceuticals Inc.
$16
Kowa Pharmaceuticals America, Inc.
$15
Tolmar, Inc.
$14
Medtronic MiniMed, Inc.
$13
Top 3 companies account for 30.8% of all-time payments
Associated products mentioned in payments ›
AFREZZA · BAQSIMI · BD Nano 2nd Gen Pen Needle · BYDUREON · CONTRAVE · CYCLOSET · CeQur Simplicity · Crysvita · Dexcom G6 Transmitter · EVENITY · EVERSENSE 365 SENSOR KIT (RETAIL) · FARXIGA · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre Pro · GVOKE HYPOPEN · GVOKE PFS · HUMULIN · HUMULIN R 500 · INTELLIS ADAPTIVESTIM · INVOKANA · JARDIANCE · JATENZO · Kerendia · Korlym · LANTUS · LEQVIO · LICART · Livalo · MINIMED 780G · MOUNJARO · MULTAQ · NEXLETOL · NOCDURNA · NP Thyroid 60 · Omnipod · Ozempic · Prolia · QUTENZA · RECORLEV · RESMETIROM · Repatha · Rybelsus · SIGNIFOR LAR · SOLIQUA · SOLIQUA 100/33 · STRENSIQ · SYNTHROID · Saxenda · Synthroid · TEPEZZA · TLANDO · TOUJEO · TRULICITY · TZIELD · Tlando · Tymlos · UNITHROID · Victoza · Wegovy · XYOSTED · Xultophy 100/3.6 · iLet Bionic Pancreas · iPro2 · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for an endocrinology specialist in Katy?
Compare endocrinologists in the Katy area by procedure volume, costs, and industry payment transparency.
Browse endocrinologists nearby

Geographic Context

Endocrinologists in nearby ZIP areas
117
County median income
$113,409
Nearest hospital to ZIP centroid (approximate)
MEMORIAL HERMANN KATY HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Subramanian is a clinical cardiology specialist, with moderate Medicare volume, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Subramanian experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Subramanian performed 782 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Subramanian receive payments from pharmaceutical companies?
Yes. Dr. Subramanian received a total of $8,971 from 46 companies across 489 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Subramanian's costs compare to other endocrinologists in Katy?
Dr. Subramanian's average Medicare payment per service is $74. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Subramanian) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →